News on 23andMe
There has been 54 news on 23andMe in the past from 23 sources across 4 sections.
Access to all news on this scope:
See the trend on this scope:
Evolution through time
Sentiment analysis
Current sentiment polarity: neutral with a score of 0.02
neutral | 4% |
Sentiment polarity through time
Latest news
23andMe special committee again rejects CEO Wojcicki's take-private offer
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
23andMe is exploring strategic alternatives, looking to raise capital
23andMe must secure its DNA databases immediately
Inside 23andMe CEO Anne Wojcicki's vision for the company: It "will transform health care"
23andMe CEO discusses rebuilding trust
23andMe is ending its cancer research program and slashing over 200 jobs
Victims of 23andMe's Data Breach Could Get $10,000. Here's What You Need to Know
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
What happens to customer data as 23andMe goes out of business?
23andMe cuts 40% of staff in restructuring
23andMe is laying off 40 percent of its staff
23andMe is laying off 40% of its workforce right before the holiday season
Struggling 23andMe cuts 40% of workforce in restructuring
23andMe Lays Off 40% of Its Workforce as Company Spirals
23andMe warns of 'substantial doubt' over its survival without new funding
What's happening with 23andMe? Mass layoffs and restructuring are the latest blow for the embattled DNA testing company
Are You Eligible for Up to $10,000 from 23andMe's Data Breach Settlement?
Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup
Sections
The coverage spans across 4 sections:
Sources
There has been 23 news sources reporting on this, including: CNBC News (11%), CBS (11%), Fast Company (9%), Financial Times (7%), and TechCrunch (7%).
Going further
Stay up to date:
Details
This content is available under the CC BY 4.0 license.